凝血酶原

凝血酶原时间延长早产儿体内的维生素K水平

Vitamin K status of preterm infants with a prolonged prothrombin time

采用Quick法测定大鼠凝血酶原时间。

Prothrombin time was determined by quick method .

凝血酶原片段F（1+2）的检测及其临床意义

Determination of Prothrombin Fragment 1 + 2 and it 's Clinical Significance

目的探讨凝血酶原（FⅡ）G20210A基因多态性与脑卒中的关系。

Objective To explore the relationship between polymorphism of prothrombin gene and stroke .

围体外循环手术期凝血因子X和凝血酶原时间检测的价值

The value of measurement of Factor X and PT in cases with peri-operation of extracorporeal circulation

经纤维蛋白凝结实验分析，采用上述方法制备的猪凝血因子V具有较高的促凝血酶原活化活性。

The prepared porcine factor V had a remarked activity identified by fibrin clotting assay .

异常凝血酶原N端F1片段及其抗血清的制备

Preparation of Abnormal Prothrombin Fl Fragment and Its Antiserum

急性心脑血管血栓性疾病患者血浆FⅦ：C、FⅧ：C、凝血酶原及纤维蛋白原的变化

Changes of Plasma F ⅶ: C , F ⅶ: C , Prothrombin and Fibrinogen in Acute Cerebrocardiac Vascular Thrombotic Disease

目的对1个遗传性凝血酶原缺乏症家系进行凝血酶原（FⅡ）基因突变的检测。

Objective To investigate the gene mutations in a pedigree with inherited prothrombin ( F ⅱ) deficiency .

SPF级封闭群SD大鼠血清生化值及凝血酶原时间值的测定

Serum Biochemical and Prothrombin Reference Rangers of SPF Closed Colony SD Rat

采用酶联免疫吸附法（ELISA）测定各组患者血浆凝血酶原片段1+2（F1+2），D-二聚体浓度。

Prothrombin fragment 1 + 2 ( F 1 + 2 ) and D dimer were measured by ELISA .

目的分析影响凝血酶原时间国际标准化比值（internationalnormalizedratio，INR）一致性的因素。

Objective To investigate the factors that influence the consistency of international normalized ratio ( INR ) of prothrombin time .

使用EDTA抗凝血检测凝血酶原时间

Use of EDTA Samples for Prothrombin time Measurement

必须定期检查凝血酶原时间（PT），或做其他相应的凝血试验来控制剂量。

Dosage should be controlled by periodic determinations of prothrombin time ( PT ) or other suitable coagulation tests .

对80例次围体外循环手术患者动态检测凝血因于X（FX）和凝血酶原时间（PT）。

Factor X and PT were dynamically measured 80 times in 16 cases with peri-operation of extracorporeal circulation .

使Ca2+激活猪凝血酶原的实验条件得以确立。在Ca（OH）2碱性条件下亚硫酸钙对矿渣的激发作用研究

The experimental condition for Ca 2 + activating porcin prothrombin was established . Research of Calcium Sulfite on Activating Slag Hydration under the Calcium Hydrate Alkali Condition

目的探讨中晚期肝病患者凝血酶原时间（PT）的标准化形式。

Objective To determine which expression mode of prothrombin time ( PT ) might achieve PT standardization in patients with advanced liver diseases .

目的探讨布加氏综合征（Budd-Chiarisyndrome，BCS）患者血浆凝血酶原时间（PT）的变化情况。

Objective To investigate the changes of prothrombin time ( PT ) in patients with Budd-Chiari Syndrome ( BCS ) .

目的探讨凝血酶原活性（FⅡ：CA）与老年肝病患者肝功能的关系。

Objective To evaluate the effect of plasmal prothrombin coagulative activity ( factor ⅱ coagulative activity , F ⅱ: CA ) on old age with liver diseases .

与凝血酶原活动度（PTA）及血清白蛋白（ALB）呈负相关。

It was negatively related with plasma prothrombin activity ( PTA ) or plasma albumin level .

凝血酶原活性进一步增加，治疗结束PTA（凝血酶原活动度%）值重庆医科大学博士研究生论文63.9士21.4，Pl人增加率：43.5士41.5%。

The value were 63.9 + 21.4 % , and the rate of increase was 43.5 + 41.5 % .

术后根据凝血酶原时间（PT），使用普通肝素或低分子肝素预防性抗凝。

Regular heparin or low-molecular-weight heparin as a prophylactic anticoagulation therapy was maintained during and after ( operation ) as indicated by prothrombin time .

减轻静脉血栓的湿重、干重（p＜0.05，p＜0.01），延长凝血酶原时间和部分凝血活酶时间（p＜0.05，p＜0.01）；

Could reduce the wet and dry weight of vein thrombus ( p < 0.05 , p < 0.01 ) and prolong the prothrombin time and partial thromboplastin time ( p < 0.05 , p < 0.01 );

生化检查结果发现当血硒浓度上升到1μg/ml（硒日摄入量850μg）时，凝血酶原时间延长的病例显著上升；

Biochemical parameters indicate that cases of delay blood prothrombin time distinctly increases as blood-Se level increases to beyond 1 μ g / ml ( daily Se intake 850 μ g ) .

方法采用ELISA法检测血清凝血酶原前体蛋白水平，它是反映机体维生素K缺乏最敏感的指标。

Methords We adopted ELISA to measure the level of serum precursor of prothrombin , which is the most sensitive target of reflecting lack of vitamin k in human body .

防风有效部位中剂量和大剂量能延长凝血酶原时间和抑制由ADP诱导的血小板聚集。

Prothrombin time was prolonged and ADP-induced platelet aggregation was inhibited in middle and high dose group .

方法应用PCRRFLP分析方法，检测了80名脑血栓患者和80名健康对照者的凝血酶原基因20210位的突变情况。

Methods Using PCR-RFLP assay , we determined 80 patients with cerebral thrombosis and 80 healthy controls for the prothrombin gene 20210 G → A.

对凝血酶原和部分凝血活酶时间的延长作用，巍山居群＞简阳居群＞新乡居群和吉木萨尔居群（后两者间P＞0.05）。

The effects on prolonging prothrombin time and partial thromboplastic time from long to short were Weishan population , Jianyang population , Xinxiang population and Jimusa ′ er population ( P > 0.05 between the last two populations ) .

总胆红素、凝血酶原时间变化亦优于对照组（P＜0.05），但丙氨酸转氨酶治疗后2组间无明显差别（P＞0.05）。

The changes of serum bilirubin and prothrombin time in treatment group were superior to that in control group ( P0.05 ), but there was not significant difference of ALT change between treatment group and control group ( P0.05 ) .

方法：凝固法测凝血酶原时间（PT），活化的部分凝血活酶时间（APTT），凝血酶时间。

Methods : coagulate determined prothrombin time ( PT ), activated partial thromboplastin time ( APTT ) and thrombin time ( TT ) .